These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34887645)

  • 1. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases.
    Kawanaka M; Nishino K; Kawamoto H; Haruma K
    World J Gastroenterol; 2021 Nov; 27(43):7497-7508. PubMed ID: 34887645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
    Mason WS; Gill US; Litwin S; Zhou Y; Peri S; Pop O; Hong ML; Naik S; Quaglia A; Bertoletti A; Kennedy PT
    Gastroenterology; 2016 Nov; 151(5):986-998.e4. PubMed ID: 27453547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver pathological changes and clinical features of patients with chronic hepatitis B virus infection in their immune tolerant phase and non-active status].
    Li J; Zhao GM; Zhu LM; Li Y; Xin SJ
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):326-9. PubMed ID: 17524261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural history of chronic hepatitis B].
    Fonseca JC
    Rev Soc Bras Med Trop; 2007; 40(6):672-7. PubMed ID: 18200423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts.
    Wu JF; Chang MH
    J Biomed Sci; 2015 Oct; 22():92. PubMed ID: 26487087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural History and Treatment Indications of Chronic Hepatitis B].
    Sinn DH
    Korean J Gastroenterol; 2019 Nov; 74(5):245-250. PubMed ID: 31765552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating Immune-tolerant Hepatitis B.
    Tseng TC; Kao JH
    J Viral Hepat; 2015 Feb; 22(2):77-84. PubMed ID: 25424771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of hepatitis B virus infection: an update for clinicians.
    Pungpapong S; Kim WR; Poterucha JJ
    Mayo Clin Proc; 2007 Aug; 82(8):967-75. PubMed ID: 17673066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
    Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
    J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.
    Habersetzer F; Moenne-Loccoz R; Meyer N; Schvoerer E; Simo-Noumbissie P; Dritsas S; Baumert TF; Doffoël M
    Liver Int; 2015 Jan; 35(1):130-9. PubMed ID: 25145784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of chronic HBV infection and geographical differences.
    Liaw YF; Brunetto MR; Hadziyannis S
    Antivir Ther; 2010; 15 Suppl 3():25-33. PubMed ID: 21041901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations.
    Yuen MF; Ahn SH; Chen DS; Chen PJ; Dusheiko GM; Hou JL; Maddrey WC; Mizokami M; Seto WK; Zoulim F; Lai CL
    J Clin Gastroenterol; 2016 Apr; 50(4):286-94. PubMed ID: 26840752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
    Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
    J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sung PS; Park DJ; Kim JH; Han JW; Lee EB; Lee GW; Nam HC; Jang JW; Bae SH; Choi JY; Shin EC; Park SH; Yoon SK
    Front Immunol; 2019; 10():1319. PubMed ID: 31244857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.